✦ LIBER ✦

The combination of VEGF inhibitors and anti-oestrogen therapies in breast cancer

✍ Scribed by Susana Banerjee

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hsp90 inhibitors and drug resistance in

✍ Xiangyi Lu; Li Xiao; Luan Wang; Douglas M. Ruden 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 550 KB

3505 POSTER Anti-oestrogen Therapy for B

✍ C. Huber; C. Bouchardy; R. Schaffar; I. Neyroud-Caspar; E. Rapiti; G. Vlastos; F 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Interaction of the anti-oestrogen Fulves

✍ Sally Hallam; P. Scriven; D. Shresthra; L. Wyld 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 35 KB

70 Use of anti-VEGF therapy and antiestr

✍ M.A. Berciano-Guerrero; J.R. de la Haba-Rodríguez; L. López-Sánchez; V. Hernánde 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Use of anti-VEGF adjuvant therapy in can

✍ Anil Bagri; Hosein Kouros-Mehr; Kevin G. Leong; Greg D. Plowman 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 391 KB

CITED2 and NCOR2 in anti-oestrogen resis

✍ van Agthoven, T; Sieuwerts, A M; Veldscholte, J; Meijer-van Gelder, M E; Smid, M 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 525 KB